Geron | GERN - Lucro Operacional

Preço das Ações
1.50
Mudança Diária
0 0%
Mensal
-4.46%
Anual
5.63%
Q2 Previsão
1.47




Lucro Operacional Alterar Data
Amgen USD 3.96B 464M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Cassava Sciences USD -13.55M 1.69M 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Genmab DKK 260M 199M 2025-12
Geron USD -10.79M 3.1M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.43M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Novartis USD 4.06B 437M 2025-12
Novavax USD 20.94M 100.32M 2025-12